Mezagitamab
Drug Detail
Contact
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Mezagitamab |
| Trade Name | |
| Synonyms | TAK079|TAK 079|TAK-079 |
| Drug Descriptions |
Mezagitamab (TAK-079) is a monoclonal antibody that targets CD38, which has potential cytolytic effects against CD38-expressing cells (J Immunol May 1, 2017, 198 (1 Supplement) 224.20, PMID: 32045493). |
| DrugClasses | CD38 Antibody 21 |
| CAS Registry Number | 2227490-52-8 |
| NCIT ID | C148078 |
Filtering
- Case insensitive filtering will display rows if any text in any cell matches the filter term
- Use simple literal full or partial string matches
- Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
- Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
- Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")
Sorting
- Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
- Click on any column header arrows to sort by that column
- Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Bortezomib + Dexamethasone + Lenalidomide + Mezagitamab | Bortezomib Dexamethasone Lenalidomide Mezagitamab | 0 | 1 |
| Dexamethasone + Lenalidomide + Mezagitamab | Dexamethasone Lenalidomide Mezagitamab | 0 | 1 |
| Dexamethasone + Mezagitamab + Pomalidomide | Dexamethasone Mezagitamab Pomalidomide | 0 | 1 |
| Mezagitamab | Mezagitamab | 0 | 1 |
| Mezagitamab + Subasumstat | Mezagitamab Subasumstat | 0 | 1 |
CKB BOOST